anmelden
SLI
2.310,49
PKT
-7,82
PKT
-0,34
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.10.22 | Swiss Re Hold | Jefferies & Company Inc. | |
| 28.10.22 | UBS Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | UBS Outperform | Credit Suisse Group | |
| 27.10.22 | UBS Hold | Jefferies & Company Inc. | |
| 27.10.22 | UBS Sell | Goldman Sachs Group Inc. | |
| 27.10.22 | UBS Neutral | JP Morgan Chase & Co. | |
| 27.10.22 | Novartis Sell | Deutsche Bank AG | |
| 27.10.22 | Holcim Hold | Deutsche Bank AG | |
| 26.10.22 | Novartis Market-Perform | Bernstein Research | |
| 26.10.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 26.10.22 | Novartis Underperform | Credit Suisse Group | |
| 26.10.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.10.22 | UBS Underweight | Barclays Capital | |
| 26.10.22 | Novartis Underweight | Barclays Capital | |
| 26.10.22 | UBS Buy | Deutsche Bank AG | |
| 26.10.22 | UBS Outperform | RBC Capital Markets | |
| 25.10.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 25.10.22 | UBS Buy | Jefferies & Company Inc. | |
| 25.10.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 25.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.22 | Novartis Sell | Deutsche Bank AG | |
| 25.10.22 | UBS Outperform | RBC Capital Markets | |
| 25.10.22 | Novartis Neutral | UBS AG | |
| 25.10.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 25.10.22 | UBS Buy | Jefferies & Company Inc. | |
| 25.10.22 | Novartis Buy | Jefferies & Company Inc. | |
| 24.10.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 24.10.22 | UBS Underweight | Barclays Capital | |
| 24.10.22 | UBS Underweight | Barclays Capital | |
| 24.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.10.22 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.10.22 | Givaudan Underperform | Bernstein Research | |
| 21.10.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 21.10.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 21.10.22 | Zurich Insurance Overweight | Barclays Capital | |
| 21.10.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 21.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 20.10.22 | Nestlé Neutral | Credit Suisse Group | |
| 20.10.22 | Nestlé Add | Baader Bank |
